Pyrazole compounds and uses thereof
US-11072599-B2 · Jul 27, 2021 · US
Pyrazole pyrimidine derivative and uses thereof
US12514859B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12514859-B2 |
| Application number | US-202418432931-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 5, 2024 |
| Priority date | Aug 4, 2015 |
| Publication date | Jan 6, 2026 |
| Grant date | Jan 6, 2026 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides pyrazole pyrimidine derivatives which inhibit Casein kinase I (CKI) and/or Interleukin-1 receptor-associated kinase 1 (IRAKI) and methods of their manufacture, compositions comprising them and uses thereof in methods of treating malignant disease and disorders and methods for treating inflammatory diseases and disorders.
First claim
Opening claim text (preview).
The invention claimed is: 1 . A compound having the formula: or a pharmaceutically acceptable salt thereof. 2 . A compound having the formula: or a pharmaceutically acceptable salt thereof. 3 . A compound having the formula: or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
specific for leukemia · CPC title
- C07D403/04Primary
directly linked by a ring-member-to-ring-member bond · CPC title
containing three or more hetero rings · CPC title
containing three or more hetero rings · CPC title
containing three or more hetero rings · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12514859B2 cover?
- The present invention provides pyrazole pyrimidine derivatives which inhibit Casein kinase I (CKI) and/or Interleukin-1 receptor-associated kinase 1 (IRAKI) and methods of their manufacture, compositions comprising them and uses thereof in methods of treating malignant disease and disorders and methods for treating inflammatory diseases and disorders.
- Who is the assignee on this patent?
- Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07D403/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).